Skip to main content
Caplight Logo









Nest Genomics

Nest Genomics

Private
New York City, New YorkHealthcare & Life Scienceshttps://www.nestgenomics.com/

Last Round

Seed

Jan 10, 2023

Total Funding Raised

$9M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Nest Genomics is a health technology company that provides a software platform for healthcare organizations to integrate and scale genomic programs.

Sector

Healthcare & Life Sciences

Verticals

Precision Medicine, Vertical SaaS, Healthcare Analytics

Business Model

B2B

Customer Profile

Subscription SaaS

AI Layer

Application

Keywords

clinical geneticsgenomics softwareprecision medicinegenetics copilotelectronic health recordsEHRclinical decision supportworkflow automationgenomic data integrationSMART on FHIRAI-native healthcaregenomics platformAI agent securityvibe coding

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nest Genomics Comparables

Compare Nest Genomics with similar companies based on industry and business-model similarity.

Nest Genomics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PhenoTips
83%
Arboretum LifeSciences
81%
Genetics Adviser
77%

Nest Genomics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJan 10, 2023
AcceleratorMar 1, 2022

Key People

Founding team and executive leadership

Guy Snir

Co-Founder & COO

Founding Team

Nest Genomics Investors

Notable investors and investment history

Nest Genomics investors
InvestorRounds
B Capital GroupSeed
Samsung Next TLVSeed
Y CombinatorSeed, Accelerator
Arkin Digital HealthSeed
Maven VenturesSeed
Casdin CapitalSeed
iAngelsSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 29, 2026

    Monthly visitors grew 118% MoM, reaching 8K.

  • Feb 1, 2026

    Added Mychartatradychildrens, an enterprise healthcare company, as a customer.

Nest Genomics Filings

Explore SEC and related filing metadata, where available.

Nest Genomics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nest Genomics's valuation, stock price, and market status.

Is Nest Genomics a public or private company?

Nest Genomics is a private company.

What is the current stock price of Nest Genomics?

Nest Genomics is a private company with no public stock price. No recent secondary market data is available.

How much is Nest Genomics worth (valuation)?

Valuation information for Nest Genomics is not publicly available.

Can I buy Nest Genomics stock?

Nest Genomics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nest Genomics's last funding round?

Nest Genomics's most recent funding round was Seed on January 10, 2023.

Who are the main investors in Nest Genomics?

Key investors in Nest Genomics include Y Combinator, Arkin Digital Health, Maven Ventures, Casdin Capital, iAngels.

Will Nest Genomics IPO soon?

No public IPO plans have been announced for Nest Genomics.

How can I track Nest Genomics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nest Genomics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNew York City, New York
Employee Range14
Year Founded2022
Last FundingJan 10, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?